An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
Cancer Gene Therapy, Published online: 09 November 2022; doi:10.1038/s41417-022-00552-4An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 9, 2022 Category: Cancer & Oncology Authors: Preeti Borde Nicola Cosgrove Sara Charmsaz Stephen T. Safrany Leonie Young Source Type: research

RAB3D/MDM2/β-catenin/c-MYC axis exacerbates the malignant behaviors of acute myeloid leukemia cells in vitro and in vivo
Cancer Gene Therapy, Published online: 24 October 2022; doi:10.1038/s41417-022-00549-zRAB3D/MDM2/β-catenin/c-MYC axis exacerbates the malignant behaviors of acute myeloid leukemia cells in vitro and in vivo (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 24, 2022 Category: Cancer & Oncology Authors: Jian Liu Yumiao Mai Yingjie Wang Zhiwei Chen Fei Wang Huixia Wei Qianghua Yao Source Type: research

Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development
Cancer Gene Therapy, Published online: 20 October 2022; doi:10.1038/s41417-022-00548-0Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 20, 2022 Category: Cancer & Oncology Authors: Stephen F. Madden Mattia Cremona Angela M. Farrelly Weng Hei Low Jean McBryan Source Type: research

Tumor-derived ARHGAP35 mutations enhance the Gα13-Rho signaling axis in human endometrial cancer
Cancer Gene Therapy, Published online: 18 October 2022; doi:10.1038/s41417-022-00547-1Tumor-derived ARHGAP35 mutations enhance the Gα13-Rho signaling axis in human endometrial cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 18, 2022 Category: Cancer & Oncology Authors: Hiroshi Yagi Ichiro Onoyama Kazuo Asanoma Minoru Kawakami Shoji Maenohara Keisuke Kodama Yumiko Matsumura Norio Hamada Emiko Hori Kazuhisa Hachisuga Masafumi Yasunaga Tatsuhiro Ohgami Kaoru Okugawa Hideaki Yahata Kiyoko Kato Source Type: research

Flotillin-1 palmitoylation turnover by APT-1 and ZDHHC-19 promotes cervical cancer progression by suppressing IGF-1 receptor desensitization and proteostasis
Cancer Gene Therapy, Published online: 18 October 2022; doi:10.1038/s41417-022-00546-2Flotillin-1 palmitoylation turnover by APT-1 and ZDHHC-19 promotes cervical cancer progression by suppressing IGF-1 receptor desensitization and proteostasis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 18, 2022 Category: Cancer & Oncology Authors: Hayeong Kwon Moonjeong Choi Yujin Ahn Donghwan Jang Yunbae Pak Source Type: research

MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma
Cancer Gene Therapy, Published online: 17 October 2022; doi:10.1038/s41417-022-00544-4MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 17, 2022 Category: Cancer & Oncology Authors: Sheetanshu Saproo Shashanka S. Sarkar Ekta Gupta Sourav Chattopadhyay Aarzoo Charaya Siddhant Kalra Gaurav Ahuja Srivatsava Naidu Source Type: research

Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor
Cancer Gene Therapy, Published online: 17 October 2022; doi:10.1038/s41417-022-00541-7Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 17, 2022 Category: Cancer & Oncology Authors: Benjamin Atwell Cheng-Yu Chen Matthew Christofferson William R. Montfort Joyce Schroeder Source Type: research

The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth
Cancer Gene Therapy, Published online: 14 October 2022; doi:10.1038/s41417-022-00539-1The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 14, 2022 Category: Cancer & Oncology Authors: Proa ño-Pérez Elizabeth Serrano-Candelas Eva Garc ía-Valverde Alfonso Rosell Jordi G ómez-Peregrina David Navin és-Ferrer Arnau Guerrero Mario Serrano C ésar Mart ín Margarita Source Type: research

VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4
Cancer Gene Therapy, Published online: 14 October 2022; doi:10.1038/s41417-022-00540-8VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 14, 2022 Category: Cancer & Oncology Authors: Xiaobao Shi Pengfei Zhao Gang Zhao Source Type: research

Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway
Cancer Gene Therapy, Published online: 14 October 2022; doi:10.1038/s41417-022-00542-6Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 14, 2022 Category: Cancer & Oncology Authors: Chang Liu Sijie Li Xiaoxiao Zhang Chunxiang Jin Baofeng Zhao Liying Li Qing Robert Miao Ying Jin Zhimin Fan Source Type: research

Retraction Note: Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway
Cancer Gene Therapy, Published online: 14 October 2022; doi:10.1038/s41417-022-00545-3Retraction Note: Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 14, 2022 Category: Cancer & Oncology Authors: Shida Yang Xiaobing Zhang Huiling Qu Bo Qu Xiaoxue Yin Hongmei Zhao Source Type: research

LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer
Cancer Gene Therapy, Published online: 04 October 2022; doi:10.1038/s41417-022-00537-3LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 4, 2022 Category: Cancer & Oncology Authors: Yuxiao Zheng Feng Qi Lu Li Bin Yu Yifei Cheng Minghui Ge Chao Qin Xiao Li Source Type: research

FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway
Cancer Gene Therapy, Published online: 23 September 2022; doi:10.1038/s41417-022-00530-wFUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 23, 2022 Category: Cancer & Oncology Authors: Qian Wang Chengcheng Liao Zhangxue Tan Xiaolan Li Xiaoyan Guan Hao Li Zhongjia Tian Jianguo Liu Jiaxing An Source Type: research

A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer
Cancer Gene Therapy, Published online: 23 September 2022; doi:10.1038/s41417-022-00538-2A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 23, 2022 Category: Cancer & Oncology Authors: Qun Liu Heshu Liu Xuying Huang Xiaona Fan Zeru Xiao Rui Yan Jiannan Yao Guanyu An Yang Ge Jinwei Miao Jian Liu Source Type: research

Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X
Cancer Gene Therapy, Published online: 21 September 2022; doi:10.1038/s41417-022-00534-6Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 21, 2022 Category: Cancer & Oncology Authors: Xiaoyi Zhang Jin Han Di fan Jiahong Wang Xiangdan Lin Hong Zhang Cai Zhang Jialing Bai Hailan Huang Yanting Gu Source Type: research